Cinacalcet HCl
KKCN201601
Approved small_molecule completed
Quick answer
Cinacalcet HCl for Hyperparathyroidism; Secondary, Renal is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Hyperparathyroidism; Secondary, Renal
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed